Browse Pet Safety Reports
16,682 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,682 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,682 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| May 12, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Application site pain; Application site tin... | Ongoing |
| May 10, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness | Recovered/Normal |
| May 8, 2021 | Human | Unknown | Afoxolaner | Dry skin; Erythema (for urticaria see Immune SOC); Itchy rash | Outcome Unknown |
| May 7, 2021 | Human | Unknown | Moxidectin | Injection site pain; Injection site swelling; Puncture wound; Accidental expo... | Outcome Unknown |
| May 6, 2021 | Human | Unknown | Selamectin;Sarolaner | Tingling skin; Burning sensation (skin); Dizziness | Outcome Unknown |
| May 6, 2021 | Human | Unknown | Oclacitinib Maleate | Headache; Accidental exposure | Outcome Unknown |
| May 6, 2021 | Human | Unknown | Amoxicillin | Stroke; Drug administration error | Outcome Unknown |
| May 5, 2021 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Medication error; Application site skin change NOS; Tubes, Leaking | Recovered/Normal |
| May 5, 2021 | Human | Unknown | Sarolaner | Mouth irritation; Fever | Outcome Unknown |
| May 3, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Application site tingling; Application site reddening; Application site skin ... | Recovered/Normal |
| May 1, 2021 | Human | Unknown | Selamectin;Sarolaner | Itchy rash | Outcome Unknown |
| Apr 30, 2021 | Human | Unknown | Ceftiofur Crystalline Free Acid | Puncture wound; Dizzy spell; Accidental exposure | Outcome Unknown |
| Apr 28, 2021 | Human | Unknown | Tilmicosin | Abdominal pain; Renal disorder NOS | Ongoing |
| Apr 28, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Wrong technique in drug usage process | Ongoing |
| Apr 27, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Wrong technique in drug usage process | Ongoing |
| Apr 27, 2021 | Human | Unknown | Imidacloprid; Moxidectin | Bad taste; Numbness | Recovered/Normal |
| Apr 27, 2021 | Human | Unknown | Maropitant Citrate | Puncture wound | Outcome Unknown |
| Apr 26, 2021 | Human | Unknown | Zeranol Implant | Injection site pain; Accidental exposure | Ongoing |
| Apr 26, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Application site reddening; Application sit... | Ongoing |
| Apr 26, 2021 | Human | Unknown | Spinosad; Milbemycin Oxime | Tingling sensation; Burning mouth sensation | Recovered/Normal |
| Apr 26, 2021 | Human | Unknown | Amprolium | Uncoded sign | Outcome Unknown |
| Apr 24, 2021 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site irritation; Tubes, Leaking | Ongoing |
| Apr 23, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Wrong technique in drug usage process | Ongoing |
| Apr 22, 2021 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site skin change NOS; Medication error; Tubes, Leaking | Recovered/Normal |
| Apr 22, 2021 | Human | Unknown | Hyaluronic Acid | Vision blurred | Recovered/Normal |
| Apr 22, 2021 | Human | Unknown | Florfenicol, Terbinafine, Betamethaso... | Application site burning sensation | Recovered/Normal |
| Apr 22, 2021 | Human | Unknown | Selamectin;Sarolaner | Nausea; Wrong technique in drug usage process | Outcome Unknown |
| Apr 21, 2021 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Eye itching; Burning sensation of eye; Periorbital oedema | Outcome Unknown |
| Apr 19, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Accidental exposure | Recovered/Normal |
| Apr 19, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Application site tingling; Nausea | Outcome Unknown |
| Apr 18, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Wrong technique in drug usage process | Recovered/Normal |
| Apr 17, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Generalised rash; Diarrhoea; Dizziness | Ongoing |
| Apr 16, 2021 | Human | Unknown | Amprolium | Uncoded sign | Outcome Unknown |
| Apr 16, 2021 | Human | Unknown | Tulathromycin | Injection site pain; Accidental exposure | Outcome Unknown |
| Apr 15, 2021 | Human | Unknown | Clomipramine | Headache; Accidental exposure | Recovered/Normal |
| Apr 15, 2021 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site skin change NOS; Medication error | Ongoing |
| Apr 15, 2021 | Human | Unknown | Oclacitinib Maleate | Throat tightness | Outcome Unknown |
| Apr 15, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Indigestion; Burning mouth sensation; Burning sensation of the throat; Accide... | Outcome Unknown |
| Apr 14, 2021 | Human | Unknown | Selamectin | Rash; Accidental exposure | Outcome Unknown |
| Apr 14, 2021 | Human | Unknown | Milbemycin/Lufenuron Tablets | Throat irritation; Accidental exposure | Ongoing |
| Apr 13, 2021 | Human | Unknown | Pimobendan | Feeling anxious; Appearance, Abnormal; Accidental exposure | Outcome Unknown |
| Apr 12, 2021 | Human | Unknown | Rabacfosadine | Difficulty sleeping | Recovered/Normal |
| Apr 12, 2021 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Wrong technique in drug usage process | Recovered/Normal |
| Apr 10, 2021 | Human | Unknown | Insulin Injectable Vial | Hyperglycaemia; Accidental exposure | Ongoing |
| Apr 9, 2021 | Human | Unknown | Selamectin;Sarolaner | Hives (see also 'Skin') | Outcome Unknown |
| Apr 9, 2021 | Human | Unknown | Gamithromycin | Injection site bleeding; Accidental exposure; Puncture wound | Recovered/Normal |
| Apr 8, 2021 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Flaking skin; Application site dry skin | Ongoing |
| Apr 8, 2021 | Human | Unknown | Nitenpyram | Localised rash; Skin lesion NOS; Accidental exposure | Ongoing |
| Apr 5, 2021 | Human | Unknown | Selamectin;Sarolaner | Eye pain; Accidental exposure | Recovered/Normal |
| Apr 4, 2021 | Human | Unknown | Selamectin | Vomiting; Gagging; Stomach pain; Throat pain; Accidental exposure; Emesis (mu... | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.